Neuroimaging Biomarkers for Alzheimer's Disease

Product not yet rated

This presentation explores the role of neuroimaging biomarkers in the early detection and diagnosis of Alzheimer's disease. We discuss advanced imaging techniques such as PET-CT, MRI, and amyloid imaging, and their utility in identifying preclinical and prodromal stages of Alzheimer's disease.

Key:

Complete
Failed
Available
Locked
Recorded Conference Session
Open to view video.
Open to view video. This presentation highlights recent advancements in immunotherapy for melanoma, focusing on novel treatment approaches and combination strategies. We discuss the mechanisms of action of immunotherapeutic agents, clinical trial data, and emerging biomarkers for predicting treatment response.
You must register to access.
Survey
3 Questions
3 Questions Rate 1-5
You must register to access.